Posts

Immunotherapy Drug Is Providing Exciting Results in the Treatment of Lung Cancers

Image: Sebastian Kaulitzki / Shutterstock.com

Alex was in his early 40s when he was diagnosed with Stage 4 Lung Cancer. A non-smoking, healthy man, who exercises regularly and eats relatively well is not who most people think of when they think of lung cancer.  However, people exactly like Alex are the new faces of lung cancer diagnoses. Alex is also one of a select few who qualified for a new targeted therapy drug recently approved by the FDA.

Lung cancer is the leading cause of cancer death globally, causing 1.7 million deaths a year. In the United States, it is expected to kill more than 154,000 people in 2018, but recent studies are producing credible progress in finding new drugs that, when combined with more traditional chemotherapy, are greatly improving the survival rates among lung cancer patients. The findings are dramatically changing the way physicians are treating lung cancers. “What it suggests is that chemotherapy alone is no longer a standard of care,” said Dr. Leena Gandhi, a leader of the study and director of the Thoracic Medical Oncology Program at the Perlmutter Cancer Center at New York University Langone Health.

So far, four drugs called checkpoint inhibitors, which unleash the patient’s own immune system to kill malignant cells, have been approved by the FDA. “I’ve been treating lung cancer for 25 years now, and I’ve never seen such a big paradigm shift as we’re seeing with immunotherapy,” said Dr. Roy Herbst, Chief of Medical Oncology at the Yale Cancer Center.

In the trial, patients with metastatic nonsquamous non-small cell lung cancer (NSCLC) who received the drug pembrolizumab (Keytruda) plus chemotherapy had improved overall survival and progression-free survival compared with just chemotherapy alone.  The results from the KEYNOTE-189 clinical trial were presented at the annual meeting of the American Association for Cancer Research (AACR) in Chicago on April 16 and published concurrently in the New England Journal of Medicine.

One of the main factors in the high rate of death due to lung cancer is that the disease is most often undetected until it has spread to other organs of the body. Lung cancer is the second most prevalent form of cancer in men and women and the top cancer killer among both sexes. In addition to the encouraging results from immunotherapy drugs, a newly discovered protein is showing promising results in detecting lung cancer earlier, providing new advanced treatment options to patients at the earliest stages of the disease. “The use of CKAP4 as a biomarker could change current practices regarding the treatment of lung cancer patients, and the diagnostic accuracies may be markedly improved by the combination of CKAP4 and conventional markers,” says Yuichi Sato, Division of Molecular Diagnostics, Kitasato University.

While the news of earlier discovery and new treatment options is very good, reducing risk factors for the disease remains the best approach to avoiding cancer. Exposure to tobacco smoke is one of the leading causes of lung cancer. Smoking marijuana and using electronic cigarettes may also increase the risk of lung cancer, but the actual risk is unknown. People who work with asbestos in a job such as shipbuilding, asbestos mining, insulation, or automotive brake repair and who smoke have a higher risk of developing cancer of the lungs. Exposure to radon has been associated with an increased risk of some types of cancer, including lung cancer. Having your home tested for the presence of Radon is a good and economical method for reducing the risk. Some people also have a genetic predisposition for lung cancer. People with parents, brothers, or sisters with lung cancer could have a higher risk of developing the cancer themselves.

Understanding cancer and how to treat it is constantly evolving toward the day when a cure is discovered. The cure is not here yet, but treatment options have greatly improved in recent decades. The treatments and methods used in clinical trials are promising in every environment in which they are tested. For more information on advancements in cancer detection and treatment, visit http://gettysburgcancercenter.com/.

What is Your Cancer Stage and Why is it Important to Know?

 

Image: Chinnapong / Shutterstock.com

One of the many new terms that patients hear when receiving a cancer diagnosis is “stage”. Along with a long list of other medical terminology used by caregivers to describe cancer, the stage of cancer is used to describe the level at which the cancer has progressed. The stage of cancer will determine where the disease is located, if or where it has spread, what other parts of the body it may have affected, and the patient’s estimated survivable rate. The stage is the most credible indication of the cancer’s progression at a given period of time and is determined by patient procedures and tests such as physical examinations, imaging scans, biopsies, blood tests, surgery or other genetic testing. Even though this is extremely important information, nearly half of the patients diagnosed with cancer in the past two years are unaware of their disease’s stage.

The American Joint Committee on Cancer (AJCC) recently released the latest edition of its cancer staging manual with new and updated staging for many types of cancer. Most cancer treatment centers started using the updated manual on January 1, 2018.

The specific stage of cancer can be determined by tests conducted prior to diagnosis or after a surgery has been performed. It can provide answers to questions concerning the size of the primary tumor, whether it has spread to the lymph nodes or other parts of the body and if the cancer is more or less likely to spread. The cancer’s stage will help determine the specific course of treatments, establish the likelihood of recovery, the estimated time to recovery and permit the patient to develop a roadmap for the challenges that lie ahead.

Most types of cancer have four stages:

  • Stage 0 is the stage that best describes cancer that is still located in the place it started and has not spread to nearby tissues. This stage of cancer is often highly curable, usually by removing the entire tumor with surgery.
  • Stage I cancer is usually a small cancer or tumor that has not grown deeply into nearby tissues. It also has not spread to the lymph nodes or other parts of the body and is often referred to as early-stage cancer.
  • Stage II and Stage III refers to larger tumors that have grown more deeply into nearby tissue and those that may have spread to the lymph nodes but not to other parts of the body.
  • Stage IV indicates that a cancer has spread to other organs or parts of the body and is sometimes called advanced or metastatic cancer.

Understanding your cancer stage will provide critical insight on your future treatment options, the time and direction of recovery and ultimately your likelihood for survival. It is important to be informed about all aspects of your disease so that you can be an active and well-informed participant in your own care.

A Cancer Diagnosis Does Not Mean Life is Over

GCC April Blog Image 2

In life it has been said that there are truly no absolutes. With time, all things change, nothing is forever the same. It is an outlook filled both with prospects of hope and dread but singular in its certainty. “Just when I think I have learned the way to live, life changes”, said Hugh Prather, author, lay minister, and counselor.

No one ever wants to be told they have cancer. The emotions of that moment cannot be fully understood until you have experienced it. For those born decades ago when such news brought little more than a prognosis of certain death, the diagnosis can elicit strong emotions of remorse, anger and depression. The lifetime probability of being diagnosed with cancer is 39.7% for men and 37.6% for women. “There is no denying that cancer is devastating news, but it does not mean your life is over. Millions of people cope with cancer every day. You are not alone.”

For Catherine, in 1999 and at age 31, life was good. Married with a good career, her life appeared to be tracking in a mostly positive direction. An examination to ferret out an explanation for a few minor health problems brought news that her life was about to change forever. Triple negative breast cancer wasn’t even known in 1999. The only certainty after the news was she needed chemotherapy as well as surgery and radiation to stem the progress of the disease. “My memories of that period in my life are that of anxiety underpinning and coloring everything I said and did,” says Catherine. “I was at a very low ebb at this stage and my family weren’t sure how we could overcome this, as all of us were flailing around trying to make sense of this terrible period in our lives.”

Planning a normal future beyond the cancer diagnosis is pre-empted by the promise of months or even years of invasive treatments, drug protocols, clinical trials and the accompanying continuing life-maintenance issues. Taking out the trash, mowing the lawn and getting the kids to soccer practice suddenly takes on a different perspective and position in life’s scale of importance. However, planning for and visualizing a future can be the very act that can assure and expedite recovery. After fourteen years, Catherine received news that her cancer was out of remission.

“I figured that this must be the beginning of the end as I was lucky to get nearly fourteen years remission. This time around, I was told my tumor was triple negative breast cancer. I was horrified and terrified on reading the statistics. I could not think past a month at a time, and holidays and family events were all abstract events. Again my mind went into a tailspin as I tried to deal with my worst fear. I then realized I probably had triple negative breast cancer before but didn’t realize how aggressive it was back in 1999 and I survived. What is not to say that this can happen again?” She is approaching her 50th birthday and no longer thinks of the future. “I have opened myself to all possibilities and am letting life happen. One of my goals was to start blogging once I felt well again and hopefully bring hope to some of my fellow triple negative breast cancer survivors.”

As a teenager in 2015, Chandler Bankos was diagnosed with advanced, stage 2 Hodgkin’s Lymphoma. An athletic and seemingly healthy seventeen year old, Chandler’s news that he had cancer wasn’t made any easier by knowing that the most common age of diagnosis of this cancer is between 20 and 40 years of age. A positive and outgoing personality, Chandler found help and treatment at the Gettysburg Cancer Center in Gettysburg, Pennsylvania. There he found experienced professionals who are dedicated to treating not only the science of his disease but the personal emotional conditions that often accompany a cancer diagnosis and regiment of treatment.

Chandler speaks of his year-long experience with cancer treatment. “If I had one thing to take away from this past year, it’s to never turn back and keep looking forward. To everyone who walked with me, fought with me, prayed for me and supported me, thank you. Today, I am officially done with everything pertaining to my fight. I completed my final surgery and I am proud to say: I am clear, I am healthy and I am moving on. I can now focus on living my life and enjoying everything it gives me. Life can be short, life can throw you around,but it all depends on how you take those negatives, and build yourself up.”

For Catherine and Chandler, cancer diagnosis didn’t mean their lives were over. Through all the pain of treatment and the turmoil it brought, they moved forward in their belief that a new life of joy and accomplishment was just beyond the struggle against their disease.

Limit Exposure to Harmful Ultraviolet Rays to Lower Your Risk of Skin Cancer

GCC April Blog Image 1

The most common type of cancer diagnosed each year in the United States is skin cancer. Most skin cancers are the result of too much exposure to sunlight or ultraviolet rays. In recent decades people have become aware of the cause and have taken steps to avoid over exposure to harmful ultraviolet rays from the sun or from tanning beds and tanning lamps.

There are three types of skin cancer.  Basal cell carcinoma, the most common type of cancer, presents itself as a recurring and sometimes bleeding sore.  Squamous cell carcinoma, the second most common type of skin cancer, begins in squamous cells (thin, flat cells) that are most commonly found in the tissue on the surface of the skin. Neither of these skin cancers spread to other parts of the body and can generally be successfully treated with surgery, radiation or topical chemotherapy.

Melanoma, which originates from pigment-producing skin cells (melanocytes), is the least common but potentially deadliest form of skin cancer. Melanomas can develop anywhere on the skin, but are often present on areas of the body which receive the most exposure to sunlight. The National Cancer Institute estimates about 87,110 new melanomas were diagnosed in 2017.

Some people are more prone to melanoma than others; those with fare skin tone and high freckle density, red or light-colored hair and those with a family history of the disease. The World Health Organization (WHO) estimates that around 60,000 early deaths occur each year worldwide because of excessive exposure to the sun’s ultraviolet (UV) radiation. An estimated 48,000 of these deaths are from malignant melanoma. Early detection can be difficult but regular inspections of the skin for alterations in appearance can detect signs of the disease. Look for skin changes, such as a new spot or mole or a change in color, shape, or size of a current spot or mole; a skin sore that fails to heal or becomes sore of painful to the touch, or a lump that looks shiny, waxy, smooth, or pale. Others may bleed or appear ulcerated or crusty to the touch.

Melanomas that are undetected and untreated will spread to other parts of the body and may become life threatening if not caught and treated in the earliest stages. Surgery is often the first approach. Lesions and surrounding tissue are removed, and a biopsy is taken to determine if the cancer has spread into the lymph nodes. In less common cases, chemotherapy or immune therapy is warranted.

The Federal Drug Administration (FDA) has recently approved the drug nivolumab for stage III melanoma. An adjuvant therapy for stage III melanoma, studies have indicated that the immunotherapy delayed recurrence of the disease with fewer side effects.  Awny Farajallah, MD, head of U.S. medical oncology for Bristol-Myers Squibb, says, “We’re very excited about the approval of adjuvant nivolumab. To date, 71 to 85 percent of stage III patients will have a recurrence, and this gives us an important additional option to bring those numbers down. Adjuvant therapy is an important part of our efforts to advance cancer treatment through immuno-oncology, with the ultimate goal of providing a potential cure.”

As with all cancers, lessening exposure to the risk factors is the best plan of action. Avoid sun burns. Wear clothing that protects exposed areas of the body. Use sunscreen with a sun protection factor (SPF) of 20-30 and a 4 or 5-star UV rating. If you have a job that exposes you to constant sunlight, take all available precautions to minimize your exposure.

Cigarette Smoking a Leading Cause of Preventable Death in United States

GCC February Blog Image 1

On the last Sunday in November 2017, television viewers and print media readers experienced a dramatic moment that continues into this year. The three major U.S. tobacco companies were ordered by the Federal Drug Administration (FDA) to issue the first in what will be a series of five “corrective statements” about their products. The corrective statements are the result of a federal racketeering lawsuit brought against the tobacco companies in 1999 by the Department of Justice. These court-ordered statements, which cover five different topic areas, explain in detail and in plain language the reality of the health harms inflicted by tobacco products upon users. Not that the harmful effects of cigarette smoking on a smoker’s health is anything new. Since the 1960’s, smokers and non-smokers alike have been bombarded with packaging warnings, public awareness campaigns and tobacco advertising bans. In case someone missed the multitude of discussions, the new statements should leave little doubt about the dangers of smoking tobacco.

Cigarette smoking is the leading cause of preventable death in the United States, causing nearly 30 percent of cancer deaths across the country. Of the more than 7,000 chemicals in tobacco smoke, at least 250 are known to be harmful, including hydrogen cyanide, carbon monoxide, and ammonia. Among those, at least 69 can cause cancer. While we are all aware that smoking causes cancer, smoking also harms nearly every bodily organ and organ system in the body and diminishes a person’s overall health. Among the cancers caused are: lung, esophagus, larynx, mouth, throat, kidney, bladder, liver, pancreas, stomach, cervix, colon, and rectum, as well as acute myeloid leukemia. Smoking also causes heart disease, stroke, aortic aneurysm, chronic obstructive pulmonary disease (COPD) (chronic bronchitis and emphysema), diabetes, osteoporosis, rheumatoid arthritis, age-related macular degeneration, and cataracts, and worsens asthma symptoms in adults. There is no safe level of smoking. Smoking even just one cigarette per day over a lifetime can cause smoking-related cancers and premature death.

Despite all the good reasons to quit, kicking the smoking habit is extremely difficult. Studies show that most smokers picked up the habit as a teenager. Cigarettes contain various amounts of Nicotine, the highly addictive drug primarily responsible for a person’s addiction to tobacco products, so quitting can be very difficult even for those already diagnosed with cancer. A study by American Cancer Society researchers found that about 1 in 10 cancer survivors still reports smoking about 9 years after a cancer diagnosis. Lead author Lee Westmaas, PhD, American Cancer Society Director of Tobacco Control Research, says, “Doctors and health care providers must continue to ask survivors about their smoking and provide resources, including medications and counseling, to help them quit.”

Cessation has immediate benefits to a smoker. Ex-smokers suffer from fewer illnesses, lower rates of pneumonia and are healthier overall than people who continue to smoke. Regardless of age, smokers can substantially reduce their risk of bad health. Smokers who quit before age 40 reduce their chance of dying prematurely from smoking-related diseases by about 90%, and the reduction for those who quit by age 45-54 is about two-thirds.

The National Cancer Institute (NCI) and other agencies and organizations can help smokers quit. For more information on organizations that can help you quit smoking, contact the NCI Smoking Quitline at 1–877–44U–QUIT (1–877–448–7848) for individualized counseling, printed information, and referrals to other sources.

The Best in Cancer Care Across the Community

September Blog 2 Image

Healthcare and access to quality healthcare is a critical issue for individuals whether healthy or recently diagnosed with a life-threatening illness.  Most patients have experienced a private medical practice being merged into a large healthcare system and often don’t understand how that will impact their care.

While large specialized health centers can promise to offer the most advanced techniques, facilities and methods, they are usually located in large urban centers, often miles and driving hours from the patient’s home, requiring long and physically taxing commutes for frequent treatments. Although staffed with caring and competent professionals these mega centers can often feel overly clinical and crowded, giving the patient a sense of being just another number among many.

The best and most advanced treatment and care is becoming less centralized, allowing for advanced specialized care to be available within the patient’s own community, providing ease of care access and reducing the personal stresses often accompanying cancer therapy.

Gettysburg Cancer Center (GCC) has been a leader in Oncology Care in the Adams County region since 1989. For more than 25 years, the highly regarded and vastly experienced medical specialists have been committed to providing cancer care in a community-based setting close to their patient’s home. The all-encompassing oncology and hematology programs provide a complete range of diagnosis, treatment, and follow-up care in an environment that recognizes the importance of treating not only the disease but the individual person behind the disease.

With Medical Oncology, Radiation Oncology, Diagnostic Imaging, access to the latest clinical trials as well as an onsite laboratory and pharmacy, Gettysburg Cancer Center truly offers comprehensive cancer care. Their compassionate and experienced staff takes pride in providing the best possible care and personal assistance to their patients and their patient’s families. Dr. Satish Shah, Principle Medical Oncologist and Hematologist at GCC says, “Our mission is to provide individualized treatment, utilizing the best technical approach.  We focus on providing the best treatment in the right environment so that our patients can focus on getting better.”

To learn more about how GCC’s is helping their cancer patients, click on http://gettysburgcancercenter.com/about-us/testimonials/.

The Importance of Connecting Patients with Clinical Trials in Cancer Research

July Blog 2 Image

Clinical Trials are at the heart of medical research and are critical to finding new paths to prevent, detect and advance new treatment methods and medications for debilitating diseases. Patients with an illness or disease participate in Clinical Trials in order to receive the benefits of the newest treatment options for recovering from their disease and to offer the best opportunity for researchers to find better treatments for others in the future. Treatments may involve new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe and may also investigate other aspects of patient care, such as improving the quality of life for people with chronic illnesses.

Providing information to patients, who have been diagnosed with a serious disease, about the specifics and availability of important Trials that may be of benefit to them is proving to be challenging.  ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants being conducted around the world and currently lists 247,989 studies with locations in all 50 States and in 201 countries. But accessing, understanding and utilizing this important data can be difficult and challenging for the average patient undergoing the emotional and physical experience of a recent diagnosis.

Former FDA commissioner Dr. Robert Califf recently delivered a talk, “Finding the Right Balance in Learning about Therapies”, at a conference in New York City. In his address he said, “Our country is experiencing an unprecedented divergence of health outcomes that mirrors gaps in wealth and education…wealthy, highly educated people are benefiting from information that allows them to lead longer, more functional lives, while others are suffering. The clinical trials enterprise has gone awry,” he said. “It’s become unnecessarily expensive, cumbersome and arcane” In his opinion the system has become so costly and onerous that most of the important questions go unasked. “Doctors are heavily conflicted between patients and the institutions they work for,” says Dr. Robert. “The rosy view that doctors and patients are discussing all options and making the best decisions flies in the face of all evidence.”

The research and pharma industry is attempting to create new pathways to connect patients with the data and, most importantly, help them understand which clinical trial is best for their particular disease. The “Innovation and Clinical Trial Tracking Factbook 2017”, is an Assessment of the Pharmaceutical Pipeline listing the thousands of new drugs currently under trial across the U.S. and around the world. VitalTrax taps into a global database of clinical trials and ultimately organizes the complex web of information into a platform that allows patients, physicians, caregivers, and families to search for relevant trials in relevant locations – in a language they can understand.

Zikria Syed, CEO of VitalTrax says his company is taking an “Open Table” approach to enrolling patients in clinical trials. “We’re making a big bet on the fact that patients would appreciate tools that put the information, and an ability to learn about clinical trials and enroll, in their own hands.”

In smaller communities around the country local oncology providers are shortening the gap of distance and time for patients seeking the benefits of clinical trials. At the Gettysburg Cancer Center (GCC), Clinical Trials are available to patients who want to participate in this important process. The localized opportunity voids the often long drive to large regional healthcare centers for Trial participants and enhances the patients understanding of the technical and practical elements of the process in a personalized but highly qualified environment.

GCC, a leader in Oncology Care across the Central Pennsylvania region since 1989, is actively involved in providing the latest in clinical trials to their patients throughout their community.

Cancer Diagnosis: A Second Opinion Can Often Lead to the Best Treatment Plan

Most of us would not consider making a major modification to our home without consulting a number of professionals or contractors. After all, getting more than one perspective on the scope of work can reveal a clear understanding of the costs, the potential inconveniences of the process, better prepare for the complexities of the work and more clearly define our expectations. Few of us would argue against the benefits of investing the time and patience in getting a second opinion.

Research shows that half of the patients diagnosed with serious illnesses such as cancer, never seek a second opinion before embarking on a series of treatments for a sometimes life threatening disease. The data reflects that only three percent considered a second opinion to be essential before accepting a diagnosis or course of action. Considering complexities of cancer and the importance of selecting the right course of action for each specific type, it is not just a good idea to initiate a second opinion, it is imperative to understanding all your options and establishing confidence in your final decision. Such important health decisions should be made only after you have learned all you can about your diagnosis, prognosis, available and treatment options.

Several reasons why so many fail to seek a second opinion can be easily explained. A cancer diagnosis is scary; and many patients feel a need to act immediately on a course of treatment to have the best chance of survival. But while in some cases taking immediate action is imperative, most cancer patients have time to learn all there is about their disease before setting out on the treatment journey. Others feel a sense of unquestioned confidence in their personal physician’s ability to diagnose and treat their condition. They often feel that questioning their results could be seen as an insult to their doctor.

Medicine is not an exact science. Even new advancements in treatment options, even the most dedicated and conscientious of practitioners cannot be expected to have the latest science at their fingertips. Many doctors are not only very comfortable with their patients seeking a second opinion, most routinely recommend the action. The results of  “a 2006 study found that when breast cancer patients came to a specialty center for a second opinion, recommendations for surgery changed for more than half, a result of different interpretations and readings of mammograms and biopsy results.”

After Greg Walde received an initial oncology evaluation and treatment at a local oncology center in Gettysburg, Pennsylvania he was told, that due to the advanced stage of his disease, he had little time to live. He was informed that there simply were no effective treatment options for his advanced stage of cancer. The disease, he was informed, had just progressed too far. “At that point,” Greg says, “I went home, very down about things”. After several weeks of distress and depression over his situation he decided to seek another opinion at The Gettysburg Cancer Center just down the street from where he had previously received the bad news. In Greg’s case the value of a second opinion included new treatment options and more time at living his life.

When faced with a cancer diagnosis it becomes critical to find the right oncology center with the experience and dedication to provide the latest and most appropriate medical treatment and support available to fight the battle. At his Gettysburg Cancer Center in Gettysburg, PA, Dr. Satish Shah, Medical Oncologist/Hematologist says, “We understand that every person is unique. Our team is dedicated to providing the latest approaches to treatment in a caring environment for patients and their families to insure the best possible outcome for their cancer treatment.”

For more information on the Gettysburg Cancer Center, visit www.gettysburgcancercenter.com.

WHAT YOU NEED TO KNOW: CANCER AWARENESS MONTH

GCC APril Blog 2

Cancer awareness month has its origin in the 1980’s when a small grassroots organization, Susan G. Komen, was formed to raise money and public awareness for breast cancer. The group created the now famous pink ribbon in order to create “brand awareness” for breast cancer and to generate much needed funding for cancer research, early detection and ultimately the diseases eventual cure.

The breast cancer program’s success spawned an important and growing expansion of the awareness campaign to cancers across the diseases spectrum. Many non-profit cancer organizations have gravitated towards the goals of the program and have originated specific colors and month of the year to represent their individual identities. The month of May represents three brands of cancers; Brain Cancer, Melanoma/ Skin Cancer and Bladder Cancer.

Brain tumors are growths of abnormal cells in tissues which originate in the brain or spinal cord. Tumors may be benign or malignant and affect nearby areas of the head and neck but rarely spread to other parts of the body. Symptoms vary and are dependent upon where the tumor forms, its size, how fast it is growing, and the age of the patient. More than 150,000 people are living with brain cancer with less than one percent of men and women likely to experience brain and nervous system cancer in their lifetime. Nearly 34 percent of brain cancer victims can expect to survive five years or more with early detection and aggressive treatment. Brain cancer is an extremely complex disease requiring a team of multi specialists including oncologist, primary care physicians and radiation oncologist. Each patient treatment protocol depends on the location of the tumor, its size and type, the patient’s age, and the overall medical condition of the patient. Brain Cancer is represented by the color grey in the month of May.

Melanoma, represented by the color black, is the most dangerous form of skin cancer and is most often caused by over exposure to ultraviolet radiation from sunshine or tanning beds. Cancerous growths develop when unrepaired DNA damage to skin cells initiate mutations that multiply rapidly and form malignant tumors. Discovered in its early stages and treated, skin cancer is almost always curable. But left untreated it can advance and spread to other parts of the body, where it becomes hard to treat and can be fatal. Depending on the stage of the disease treatments may include; surgery, immunotherapy, targeted therapy, chemotherapy and radiation.

Bladder Cancer originates when healthy cells in the bladder lining change and grow rapidly forming a tumor. Malignant tumors may spread to other parts of the body if left untreated. The three most common types of bladder cancer are; Urothelial carcinoma, Squamous cell carcinoma and Adenocarcinoma. Represented by the awareness color Marigold/Blue/Purple, bladder cancers are most often detected in patients by the presence of blood in the urine, frequent or burning sensation when urinating or lower back pain. Treatment options include; surgery, chemotherapy, immunotherapy and radiation. Treatment protocols are dependent upon the stage of the cancer, patient’s health, treatment preferences and potential side effects.  Bladder cancer mostly affects older people with an estimated 79,000 adults expected to be diagnosed with bladder cancer in the United States each year. With early detection the 10 year survival rate for bladder cancer is 70 percent.

Increased awareness has had a proven and positive effect on early diagnosis and treatment of various cancers and has resulted in a better educated and prepared patient. Utilizing this marketing approach the stigma once associated with cancer has been greatly diminished.

The Value of a Second Opinion Provides Alternative Treatment to a Cancer Patient

When faced with a cancer diagnosis, it becomes critical to find the right oncology center that will provide the appropriate medical treatment and emotion support to fight the battle. One Gettysburg resident, when faced with a stage-4 cancer diagnosis, found the right support at Gettysburg Cancer Center (GCC), a growing comprehensive cancer center.

Greg Wale received an initial oncology evaluation and treatment at another local oncology center in Gettysburg, Pennsylvania. The diagnosis showed that cancerous tumors had grown to 4 and 5 inches in diameter and had migrated to the liver, bone, thyroid glands and colon. Greg was just 57 year’s old and was told by oncologists that he had little time to live. There simply were no treatment options for his advanced stage of cancer. The disease, he was informed, had just progressed too far.

“At that point,” Greg says, “I went home, very down about things”. After several weeks of distress and depression over the state of his situation, he drew upon his faith and was “spiritually lead” to the Gettysburg Cancer Center (GCC), just down the block from where he had previously received the bad news. It was here that the centers principle oncologist, Dr. Shah, sat down with Greg to review his case. “I felt very comfortable here where there was a lot of very concerned people with caring hearts,” recounts Greg.

He immediately felt the staff at GCC wanted to help and he sensed that things were going to be different in this place where everyone seemed like family. Dr. Shah and his expert team designed a plan to attack his disease and provide as much time as possible for Greg’s future. With no guarantees, the team embarked upon an individualized course of treatment. After a couple of months, new tests revealed that the progression of the disease appeared to be slowing. According to Greg, “None of us knows how much time we have but it looks like I’m going to have more of it than what was told to me when I was first diagnosed thanks to Dr. Shah and this facility.”

For more than 25 years, Gettysburg Cancer Center has been committed to providing cancer care in a community-based setting close to home. The all-encompassing oncology and hematology programs provide a complete range of diagnosis and treatment. “Here at Gettysburg Cancer Center we understand that each patient and their disease are unique, requiring different approaches to insure the best possible outcome for each patient. Our family of caring and educated staff strives to provide insightful, compassionate care to all of our patients.” says Dr. Shah.

In this case, the value of a second opinion meant a new treatment option and more time for this cancer patient. To view the full patient testimonial: https://www.youtube.com/watch?v=448eg4F_SEg&feature=youtu.be.